Intellia Therapeutics, Inc. (NTLA): 10-Q filed Aug 6, 2026

Form type

10-Q

Filing date

Aug 6, 2026

Accession number

0001193125-26-337952

Filer

Intellia Therapeutics, Inc. (CIK 1652130)